Mon, July 18, 2022
Sat, July 16, 2022
Fri, July 15, 2022
Thu, July 14, 2022

Dan Brennan Maintained (TXG) at Buy with Decreased Target to $50 on, Jul 15th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-50-on-jul-15th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Dan Brennan of Cowen & Co., Maintained "10x Genomics, Inc." (TXG) at Buy with Decreased Target from $90 to $50 on, Jul 15th, 2022.

Dan has made no other calls on TXG in the last 4 months.



There are 3 other peers that have a rating on TXG. Out of the 3 peers that are also analyzing TXG, 1 agrees with Dan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Maintained at Hold with Decreased Target to $60 on, Thursday, July 14th, 2022


These are the ratings of the 2 analyists that currently disagree with Dan


  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $100 on, Friday, May 6th, 2022
  • Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $100 on, Thursday, May 5th, 2022

Publication Contributing Sources